South Africa

Resilience System

Main menu


Novavax vaccine study: 51% efficacy against South African variant

Biden administration commits to waiving vaccine patent protections

OVERVIEW: Rich countries to address unequal global vaccine rollout, and other developments

Why some vaccinated people still wear masks -- even outdoors

CDCcompiles data on the rates of side effects after dose of Moderna and Pfizer’s vaccines

Vaccines linked to rare clotting disorders--an analysis

Biden announces goal of at least one Covid-19 vaccine shot to 70% of US adults and increased funding for community outreach groups fund

India's virus catastrophe worsens. Hospitals turn to courts for help

NEW DELHI (AP) — COVID-19 infections and deaths are mounting with alarming speed in India with no end in sight to the crisis and a top expert warning that the coming weeks in the country of nearly 1.4 billion people will be “horrible.”

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

New Virus Waves Hit Developing Countries, Not Just India

Studying ways to change minds of cornavirus skeptics--incentives and respected figures .

European regulators are reviewing use of Pfizer vaccine for adolescents

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

More supplies for global COVAX program and Novavax plans to ship to Europe

Moderna will supply 34 million doses of its Covid-19 vaccine this year and Sweden has donated 1 million AstraZeneca shots to the global COVAX program, a small boost as it struggles to get stocks to inoculate the world’s poorest people.

The advance purchase contract agreed with Moderna is for up to 500 million doses, but the rollout will only start in the fourth quarter, with 34 million doses available this year, the GAVI vaccine alliance said on Monday.

The bulk — 466 million — would only become available next year, it said.

The deal expands the program’s pipeline of vaccines to eight and contains options to potentially access doses of variant-adapted vaccines in the future, it said.

The agreement follows the U.S. drugmaker’s shot being approved for emergency use listing by the WHO on Friday, a prerequisite for COVAX eligibility. read more

GAVI runs the COVAX vaccine sharing facility with the World Health Organization.

The Swedish donation is the second by a European Union member after France last month amid mounting concerns about growing inequity in vaccine distribution after wealthy countries built up stocks of shots for its citizens. read more

Problem, Solution, SitRep, or ?: 

India pulls trainee doctors from exams to fight world’s biggest COVID surge

More global Covid-19 cases reported in last 2 weeks than first 6 months of the pandemic --WHO

U.S. Unlikely to Reach ‘Herd Immunity’ , Experts Now Believe

Early in the pandemic, when vaccines for the coronavirus were still just a glimmer on the horizon, the term “herd immunity” came to signify the endgame: the point when enough Americans would be protected from the virus so we could be rid of the pathogen and reclaim our lives.

Now, more than half of adults in the United States have been inoculated with at least one dose of a vaccine. But daily vaccination rates are slipping, and there is widespread consensus among scientists and public health experts that the herd immunity threshold is not attainable — at least not in the foreseeable future, and perhaps not ever.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to South Africa RSS
howdy folks
Page loaded in 1.722 seconds.